Nils1975

Infineon w/a pretty bad quarter...rev/guide max in-line w/buy side, margins below. But AI (spoiler in the slides that they raise the '27 AI guide materially, a next Q thing i guess) and orders (>2x b2b, backlog +5B q/q implies ~9B in orders) might save the day imo... infineon.com/assets/row/publ… slide 55 + slide 67

Dan Ives 🦄yday initiated $PLTR at o/p w/PT $25 calling it the "Messi of AI", 2y ago pbly would have called it the "Belichick of SPACs"...2.5y ago the "LeBron of AI"...ah, wait he actually used that one for his Jan'21 init of $AI w/PT $200, cut to neutral in May'22 w/PT $16 🤡

Software AG (SOW.gy) w/surprisingly strong #s, did beat (!) decently on license #s (usually misses) & even guided fy16 rev x above cons

$SAP: license €2.15B vs 1.9B, 2.7K Hana custs vs 2K, cloud 630M vs 638M, fy16 s/w & cloud 1%>x, OM a bit light, license beat strongest in 5y

$CIEN bigger picture: rev will prob always be a bit lumpy q/q, exec on gm/om improved steadily & substantially + vz metro will ramp in fy16

$CIEN never easy to read (no trade 30m post #s) - GM/OM beat big, as does rev miss, GM/OM outlook nicely >st., ~rev in-line, fy eps moves up

msco applauds $AAPL miss: Firm thinks iPhones units miss on expectation helps de-risk 2H15

$SAP follows $ORCL, cloud beat, decent size license miss (-7% y/y)...mgmt apparently embarrassed about the licence # (v hard to find in pr)

$PHG Philips to sell 80% in lighting components arm to GO Scale Capital-led consortium reut.rs/1xRr0pJ -->raises FV for Osram >€60

$CIEN b/b >1, fx impacts next Q by 15M, so rev would have been 18M >cons in cc, reits eps guidance despite fx (lower opex, cogs)

$CIEN rev guidance actually impressing 600M vs 597.4M cons when factoring fx, 43.7% = intl, so fx prob ~ -20M since last call (if unhedged)

$CIEN always interesting Qs, big rev miss (timing & fx), bigger gm beat 44.1% vs 41.5%, guidance in line w/+ve previews, expect upbeat cc

$DDD putting lipstick on a pig as always, only co comparable is Germany's Software AG (if have time check out co's PRs on earnings misses)

$DDD same for eps, which actually is <cons + includes that accretive acq...won't be met, came in at 70c for fy14...est been at $1 1y ago

so ex that acquisition (closed feb 9) $DDD fy15 rev guidance would have fallen short as well (by ~35M)...and won't be met anyway

$DDD never met any guidance for the last year, saw as much as $1B in 15, now 875M...and the best of it, that includes an acq which adds ~40M